Suppr超能文献

双焦点乳腺癌的肿瘤间异质性:形态学和分子研究。

Intertumoral heterogeneity of bifocal breast cancer: a morphological and molecular study.

机构信息

Department of Surgical Pathology, Dietrich Bonhoeffer Klinikum, Allendestrasse 30, 17033, Neubrandenburg, Germany.

Department of Pathology, University Medical Centre Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands.

出版信息

Breast Cancer Res Treat. 2024 Jun;205(2):413-421. doi: 10.1007/s10549-024-07281-2. Epub 2024 Mar 7.

Abstract

PURPOSE

To analyze concordance rates between individual foci of bifocal BC for histological grade, type and intrinsic subtype based on immunohistochemical (IHC) and mRNA-testing using MammaTyper.

METHODS

We evaluated histological grade and type as well as intrinsic subtype based on IHC status for estrogen and progesterone receptors, HER2 and the mitotic activity index in 158 individual foci of 79 bifocal BC. A subgroup of 31 cases additionally underwent mRNA-based subtyping using the MammaTyper (MT) test. We calculated concordance rates between individual foci, as well as Cohen's Kappa (K).

RESULTS

For 79 bifocal BC, concordance rates between individual foci for grade, histological type, and IHC-based subtype were 69.6% (K=0.53), 92.4% (K=0.81), and 74.7% (K=0.62), respectively. In the MT subgroup of 31 bifocal BC, concordance rates between individual foci for grade, histological type, IHC-based and mRNA-based intrinsic subtype were 87.1% (K=0.78), 90.3% (K=0.73), 87.1% (K=0.82), and 87.1% (K=0.7), respectively. Overall concordance between IHC- and mRNA-based subtype in the MT subgroup was 79% (K=0.7). In 6/79 cases (7.6%), testing of the smaller focus added clinically relevant information either on IHC- or mRNA-level: four cases showed high hormonal receptor expression while the expression in the larger focus was negative or low, warranting additional endocrine treatment; two cases presented with higher proliferative activity in the smaller focus, warranting additional chemotherapy.

CONCLUSION

In bifocal BC, intertumoral heterogeneity on the morphological, immunohistochemical and molecular level is common, with discordant intrinsic subtype in up to 25% between individual foci, with about 8% clinically relevant discordances.

摘要

目的

分析基于免疫组化(IHC)和 MammaTyper(MT)mRNA 检测的双焦点 BC 中各焦点的组织学分级、类型和内在亚型的一致性率。

方法

我们评估了 79 例双焦点 BC 中 158 个焦点的组织学分级和类型以及内在亚型,基于雌激素和孕激素受体、HER2 和有丝分裂活性指数的 IHC 状态。31 例亚组还进行了基于 MT 试验的 mRNA 亚型检测。我们计算了各焦点之间的一致性率,以及 Cohen's Kappa(K)。

结果

对于 79 例双焦点 BC,分级、组织学类型和 IHC 基础亚型各焦点之间的一致性率分别为 69.6%(K=0.53)、92.4%(K=0.81)和 74.7%(K=0.62)。在 31 例双焦点 BC 的 MT 亚组中,分级、组织学类型、IHC 基础和 mRNA 基础内在亚型各焦点之间的一致性率分别为 87.1%(K=0.78)、90.3%(K=0.73)、87.1%(K=0.82)和 87.1%(K=0.7)。在 MT 亚组中,IHC 和 mRNA 基础亚型之间的总体一致性为 79%(K=0.7)。在 6/79 例(7.6%)中,较小焦点的检测在 IHC 或 mRNA 水平上提供了临床相关信息:4 例表现出高激素受体表达,而较大焦点的表达为阴性或低,需要额外的内分泌治疗;2 例较小焦点的增殖活性较高,需要额外的化疗。

结论

在双焦点 BC 中,肿瘤间在形态学、免疫组化和分子水平上存在异质性,各焦点之间的内在亚型不一致率高达 25%,其中约 8%存在临床相关的不一致性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验